Evidence map›Paper›PMID 33772657›Full record

ReviewCurrent atherosclerosis reports2021

The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

W Sean Davidson, Allison L Cooke, Debi K Swertfeger, Amy S Shah

Open access · greenAbstract readReview
In one paragraph

Review in Current atherosclerosis reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Vascular contribution to cognitive impairment and dementia (VCID): proceedings of 2025 workshop of the Jackson Laboratory.Mammalian genome : official journal of the International Mammalian Genome Society · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. The Lipidomic Profile Discriminates Between MASLD and MetALD.Alimentary pharmacology & therapeutics · 2025
    Article
  14. Review
  15. Article
  16. Review
  17. Lipoprotein Particles in Cerebrospinal Fluid.Arteriosclerosis, thrombosis, and vascular biology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

W Sean DavidsonDepartment of Pathology and Laboratory Medicine, University of Cincinnati, Cincinnati, OH, 45237, USA. Sean.Davidson@UC.edu.ORCID 0000-0003-2756-2989
Allison L CookeAbalone Bio, Richmond, CA, 94608, USA.
Debi K SwertfegerDepartment of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, 45229, USA.
Amy S ShahDepartment of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, 45229, USA.
Cincinnati Children's Hospital Medical Center · USTheraclone Sciences (United States) · USUniversity of Cincinnati · US

Funding

Project 3 - HDL Structure/Function in LCAT Deficient HumansP01HL128203 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI W Sean Davidson · 2016 to 2026
$25.1M
Apolipoprotein A-I structure in high density lipoproteinsR01HL067093 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2002 to 2016
$4.3M
Lipoprotein Interactions in the Vessel WallR01HL157260 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI DAVIDSON, W SEAN, SHAH, AMY SANGHAVI · 2021 to 2024
$2.2M
The structural basis for cholesterol esterification in human plasmaR01HL153118 · NHLBI · UNIVERSITY OF CINCINNATI · PI DAVIDSON, W SEAN · 2020 to 2023
$2.0M
Understanding the Role of HDL Subspecies in Adolescents with Type 2 DiabetesK23HL118132 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI SHAH, AMY SANGHAVI · 2014 to 2018
$855k
NHLBI NIH HHS K23 HL118132NHLBI NIH HHS P01 HL128203NHLBI NIH HHS R01 HL067093NHLBI NIH HHS R01 HL153118NHLBI NIH HHS R01 HL157260
6 · The paper itself

Abstract

purpose of reviewThe term high density lipoproteins (HDL) refers to an eclectic collection of subparticles that play diverse roles in physiology. Here, we define the term "HDL subspecies" and review recent work on their molecular characterization and relation to disease, focusing on cardiovascular disease and diabetes. RECENT

findingsThe HDL family contains over 200 proteins and nearly 200 lipids that partition into different particles in plasma. Simple subfractionation of HDL based on a particular physicochemical property has not risen to the challenge of revealing the roles of specific particles in disease. However, by targeting minor protein or lipid components, a handful of compositionally defined HDL subspecies have been described and characterized. By combining targeted particle isolation techniques with the power of large human studies, progress is being made in understanding HDL subspecies functions and implications for disease. However, much work remains before these advancements can be translated into disease mitigation strategies.

Indexed as

Cardiovascular DiseasesDiabetes MellitusHumansLipidsLipoproteinsLipoproteins, HDLLipidsLipoproteinsLipoproteins, HDLCardiovascular diseaseHigh density lipoproteinsLipoproteinLipoprotein subspeciesPre-beta HDLSubfractionsSubspeciesTrypanosome lytic factorType 2 diabetes

Identifiers

PMID33772657
PMCPMC8258923
OpenAlexW3146745926

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.